This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Abbott Laboratories rose 3.7% to $133.35 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.4% to 5,916.93 and the Dow Jones Industrial Average rising 0.6% to 42,322.75.
The stock's rise snapped a four-day losing streak.
Abbott Laboratories closed 5.6% below its 52-week high of $141.23, which the company reached on March 4th.
The stock outperformed some of its competitors, as Johnson & Johnson rose 2.2% to $149.61, Pfizer Inc. rose 2.6% to $22.60, and Merck & Co. Inc. rose 1.81% to $74.80.
Trading volume totaled 8.4 million, compared to the 50-day average of 7.4 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 15, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.